Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 66.80
-0.40 (-0.60%)
At close: Dec 3, 2025
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.33 billion as of December 5, 2025. Its market cap has increased by 97.89% in one year.
Market Cap
3.33B
Enterprise Value
2.93B
Revenue
159.02M
Ranking
n/a
PE Ratio
158.58
Stock Price
66.80
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.33B, an increase of 139.08%. That is a compound annual growth rate of 89.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.33B | 101.04% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Semiconductor Manufacturing Company | 37.86T |
| Hon Hai Precision Industry | 3.23T |
| Delta Electronics | 2.54T |
| MediaTek | 2.27T |
| Fubon Financial Holding | 1.30T |
| Quanta Computer | 1.15T |
| Chunghwa Telecom | 1.01T |
| ASE Technology Holding | 1.01T |